BioInnovation Ltd, was set up to investigate improvements in drug delivery in cancer and other diseases. Originating from two clinicians with their own intellectual property, Bioincubator York Ltd matched this IP with a University research group and project management skills and financing from a pharmaceutical company to progress the project through development and on to clinical trial.At time of writing (March 2004) the company is dormant as there is a dispute between the financing pharma company and Bioinnovation Ltd regarding the development of the patented molecule. The MD expects to take the development process to the University of Milan.
Latest Bioinnovation News
Aug 28, 2023
Life Sciences British Columbia Search Home » All News » adMare BioInnovations Invites Early-Career Science Professionals to Apply to the BioInnovation Scientist (BIS) Program: Foundations Cohort II All News adMare BioInnovations Invites Early-Career Science Professionals to Apply to the BioInnovation Scientist (BIS) Program: Foundations Cohort II August 24, 2023 adMare BioInnovations VANCOUVER, BC, MONTREAL, QC and TORONTO, ON – The adMare Academy is pleased to announce the opening of applications for the second cohort of the BioInnovation Scientist (BIS) Program: Foundations. This online, cohort-based program provides fundamental knowledge in therapeutics development while simultaneously building the professional skills necessary to succeed in the Canadian life sciences industry. “We are delighted to build on the success of the inaugural cohort of this program, where the participation and enthusiasm from the cohort and the demonstrated application of learning among participants was such a joy to be part of,” stated Dr. Ann Meyer, Director, BIS Program. “Feedback from participants reflected a valuable experience that will positively impact their transition to and success in commercially-focused life sciences roles and organizations.” The 8-week online program is structured into four courses that introduce therapeutics discovery, development, and commercialization. The program covers important topics such as intellectual property, the high-risk/high-reward nature of the industry, and the importance of incorporating inclusion, diversity, equity, and accessibility principles into therapeutics development. Participants work through practical activities that incorporate real-world examples, join live online discussion sessions with industry experts, and have the opportunity to build their peer networks across the country. The BIS Program: Foundations is open to individuals possessing at least a BSc. or equivalent degree, who are either newly employed in industry or working/training in academia, with a view to transition into commercial organizations. Applicants must reside in Canada and apply before the September 27th deadline using this link . For more information on the program, visit https://www.admarebio.com/en/bis-program . About adMare BioInnovations With a wealth of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent — and re-invest our returns back into the Canadian industry to ensure it is sustained for the long-term. As part of our commitment to build talent, we have created the adMare Academy, dedicated to providing the specialized training required to foster the next generation of highly qualified personnel who will drive the growth of Canadian life science companies. The adMare Academy has trained more than 500 alumni — 94% of whom are employed in the life sciences industry.
Bioinnovation Frequently Asked Questions (FAQ)
When was Bioinnovation founded?
Bioinnovation was founded in 1998.
Where is Bioinnovation's headquarters?
Bioinnovation's headquarters is located at The Innovation Centre, Heslington.
What is Bioinnovation's latest funding round?
Bioinnovation's latest funding round is Private Equity.
How much did Bioinnovation raise?
Bioinnovation raised a total of $1.25M.